These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1416793)

  • 61. Hypersensitivity to trimethoprim.
    Alonso MD; Marcos C; Davila I; de la Hoz B; Martin JA; Parra F; Diez ML
    Allergy; 1992 Aug; 47(4 Pt 1):340-2. PubMed ID: 1443457
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Changing trends in inducer drugs of fixed drug eruption: a 20-year cross-sectional study from Turkey.
    Özkaya E
    J Dtsch Dermatol Ges; 2018 Apr; 16(4):474-476. PubMed ID: 29512939
    [No Abstract]   [Full Text] [Related]  

  • 63. Co-trimoxazole toxicity in children.
    Jick SS; Jick H; Habakangas JA; Dinan BJ
    Lancet; 1984 Sep; 2(8403):631. PubMed ID: 6147653
    [No Abstract]   [Full Text] [Related]  

  • 64. Severe co-trimoxazole reaction in a man with AIDS.
    Shepherd J; Shepherd C; Tonozzi C; Boysen E
    J Am Board Fam Pract; 1995; 8(2):130-3. PubMed ID: 7778481
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical study of cutaneous drug eruptions in 200 patients.
    Raksha MP; Marfatia YS
    Indian J Dermatol Venereol Leprol; 2008; 74(1):80. PubMed ID: 18193504
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tremor induced by trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome (AIDS).
    Borucki MJ; Matzke DS; Pollard RB
    Ann Intern Med; 1988 Jul; 109(1):77-8. PubMed ID: 2967659
    [No Abstract]   [Full Text] [Related]  

  • 67. Drug monitoring during the treatment of AIDS-associated Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole.
    Klinker H; Langmann P; Zilly M; Richter E
    J Clin Pharm Ther; 1998 Apr; 23(2):149-54. PubMed ID: 9786102
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adverse reactions to co-trimoxazole in HIV infection.
    Toma E; Fournier S
    Lancet; 1991 Oct; 338(8772):954. PubMed ID: 1681303
    [No Abstract]   [Full Text] [Related]  

  • 69. Clinical study of cutaneous drug eruptions in 200 patients.
    Patel RM; Marfatia YS
    Indian J Dermatol Venereol Leprol; 2008; 74(4):430. PubMed ID: 18810845
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thrombophlebitis migrans following co-trimoxazole therapy.
    Verne-Pignatelli J; Spickett GP; Dalgleish AG; Denman AM
    Postgrad Med J; 1989 Jan; 65(759):51-2. PubMed ID: 2789377
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Topical provocation of fixed drug eruption.
    Alanko K; Stubb S; Reitamo S
    Br J Dermatol; 1987 Apr; 116(4):561-7. PubMed ID: 2953388
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical pattern of cutaneous drug eruption among children and adolescents in north India.
    Sharma VK; Dhar S
    Pediatr Dermatol; 1995 Jun; 12(2):178-83. PubMed ID: 7659648
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Co-trimoxazole toxicity.
    Lennon D
    Lancet; 1984 Nov; 2(8412):1152. PubMed ID: 6150203
    [No Abstract]   [Full Text] [Related]  

  • 74. Phenytoin toxicity and co-trimoxazole.
    Gillman MA; Sandyk R
    Ann Intern Med; 1985 Apr; 102(4):559. PubMed ID: 3872091
    [No Abstract]   [Full Text] [Related]  

  • 75. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.
    White MV; Haddad ZH; Brunner E; Sainz C
    Ann Allergy; 1989 Mar; 62(3):177-9. PubMed ID: 2522290
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial.
    Homsy J; Dorsey G; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Muhindo M; Kamya MR; Sandison TG; Tappero JW
    Lancet Glob Health; 2014 Dec; 2(12):e727-36. PubMed ID: 25433628
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole.
    Douglas R; Spelman D; Czarny D; O'Hehir RE
    Clin Infect Dis; 1997 Dec; 25(6):1480. PubMed ID: 9431406
    [No Abstract]   [Full Text] [Related]  

  • 78. Co-trimoxazole prophylaxis in leukaemia.
    Drysdale HC; Jones LF
    Lancet; 1982 Feb; 1(8269):448. PubMed ID: 6121111
    [No Abstract]   [Full Text] [Related]  

  • 79. Co-trimoxazole toxicity.
    Lacey RW; Hawkey PM; Devaraj SK; Millar MR; Inglis TJ; Godwin PG
    Br Med J (Clin Res Ed); 1985 Aug; 291(6493):481. PubMed ID: 3926242
    [No Abstract]   [Full Text] [Related]  

  • 80. Fixed drug eruptions in children.
    Tarim O; Eralp O; Uncu Y
    J Pediatr; 2000 Apr; 136(4):565-6. PubMed ID: 10753268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.